Overview

Comparison of 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD

Status:
Completed

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to compare the bronchodilator efficacy a of tiotropium inhalation via DISCAIR (18 mcg once daily) and SPIRIVA HANDIHALER® (18 mcg once daily) in patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Phase:

Phase 4

Details

Lead Sponsor:

Neutec Ar-Ge San ve Tic A.Ş

Treatments:

Bronchodilator Agents
Tiotropium Bromide